Summit Creek Advisors LLC Purchases New Holdings in HealthEquity, Inc. $HQY

Summit Creek Advisors LLC acquired a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) during the 2nd quarter, Holdings Channel.com reports. The fund acquired 84,157 shares of the company’s stock, valued at approximately $7,601,000. HealthEquity comprises approximately 2.6% of Summit Creek Advisors LLC’s holdings, making the stock its 9th largest holding.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Acumen Wealth Advisors LLC purchased a new position in shares of HealthEquity during the fourth quarter valued at approximately $27,000. Caitong International Asset Management Co. Ltd boosted its position in shares of HealthEquity by 1,723.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after purchasing an additional 293 shares in the last quarter. Aster Capital Management DIFC Ltd purchased a new stake in shares of HealthEquity in the 4th quarter worth approximately $28,000. Leonteq Securities AG grew its stake in shares of HealthEquity by 159.9% in the 1st quarter. Leonteq Securities AG now owns 382 shares of the company’s stock worth $32,000 after buying an additional 235 shares during the last quarter. Finally, Axiom Investment Management LLC bought a new position in HealthEquity during the 1st quarter valued at approximately $33,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Trading Up 0.4%

Shares of NASDAQ:HQY opened at $102.79 on Wednesday. The stock has a 50 day moving average of $95.71 and a 200 day moving average of $86.80. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. The company has a market cap of $8.59 billion, a PE ratio of 38.50, a price-to-earnings-growth ratio of 1.76 and a beta of 0.21. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $107.62.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Thursday, May 28th. The company reported $1.24 EPS for the quarter, beating the consensus estimate of $1.11 by $0.13. The firm had revenue of $354.64 million for the quarter, compared to the consensus estimate of $352.02 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. HealthEquity’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, equities research analysts expect that HealthEquity, Inc. will post 3.92 EPS for the current year.

Insider Activity

In other news, EVP Michael Henry Fiore sold 2,354 shares of the firm’s stock in a transaction dated Friday, July 10th. The stock was sold at an average price of $95.00, for a total transaction of $223,630.00. Following the completion of the transaction, the executive vice president owned 52,244 shares in the company, valued at $4,963,180. This trade represents a 4.31% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of HealthEquity stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the completion of the sale, the executive vice president directly owned 91,141 shares in the company, valued at $8,202,690. This trade represents a 7.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 17,905 shares of company stock worth $1,651,280 over the last quarter. Insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have issued reports on HQY. KeyCorp reiterated an “overweight” rating on shares of HealthEquity in a research note on Tuesday, May 26th. Wells Fargo & Company set a $111.00 target price on HealthEquity in a research note on Monday, June 1st. Wall Street Zen downgraded HealthEquity from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Barrington Research reaffirmed an “outperform” rating and issued a $110.00 price target on shares of HealthEquity in a research report on Friday, May 22nd. Finally, Royal Bank Of Canada upped their target price on shares of HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a research note on Wednesday, June 3rd. Eleven equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, HealthEquity presently has a consensus rating of “Moderate Buy” and an average target price of $110.93.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.